Skip to main content
Logistics, risks, and benefits of automated red blood cell exchange for patients with sickle cell disease.
Too many white cells-TAM, JMML, or something else?
Evolving treatment paradigms in sickle cell disease.
Chronic organ failure in adult sickle cell disease.
Emerging 'A' therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine.
Alpha thalassemia major--new mutations, intrauterine management, and outcomes.
Non-invasive assessment of tissue iron overload.
Stem cell therapy for sickle cell disease: transplantation and gene therapy.